Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

NOXXON Pharma N.V (PA: ALNOX)

 
ALNOX Technical Analysis
5
As on 15th Sep 2022 ALNOX STOCK Price closed @ 3.98 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.33 & Strong Buy for SHORT-TERM with Stoploss of 0.43 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ALNOXSTOCK Price

Open 3.93 Change Price %
High 4.00 1 Day 0.06 1.53
Low 3.75 1 Week -0.15 -3.63
Close 3.98 1 Month 3.94 9850.00
Volume 6753 1 Year 3.53 784.44
52 Week High 4.85 | 52 Week Low 0.04
 
PA France Most Active Stocks
ATO 0.00 %
ALALO 0.00 %
ALVER 0.00 %
ALEUP 0.02 100.00%
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
ORA 11.99 -0.83%
ENGI 18.43 1.43%
CGG 0.69 -2.82%
ALNRG 0.01 %
 
PA France Top Gainers Stocks
ALEUP 0.02 100.00%
CFI 0.75 50.00%
CFI 0.75 50.00%
CFI 0.75 50.00%
ALTRO 5.00 11.11%
DBV 1.26 9.57%
DBV 1.26 9.57%
DBV 1.26 9.57%
VTR 9.20 9.52%
VTR 9.20 9.52%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
ALNEV 0.04 -20.00%
FPG 0.18 -18.18%
MLOCT 0.10 -16.67%
ORP 7.90 -12.03%
MLMON 0.88 -12.00%
ALROC 0.38 -11.63%
ALDBL 3.04 -11.11%
 
 
ALNOX
Daily Charts		 ALNOX
Intraday Charts		 Whats New @
Bazaartrend		 ALNOX
Free Analysis
 
ALNOX Important Levels Intraday
RESISTANCE4.46
RESISTANCE4.31
RESISTANCE4.21
RESISTANCE4.12
SUPPORT3.84
SUPPORT3.75
SUPPORT3.65
SUPPORT3.50
 
ALNOX Forecast April 2025
Share
4th UP Forecast4.15
3rd UP Forecast4.1
2nd UP Forecast4.06
1st UP Forecast4.03
1st DOWN Forecast3.93
2nd DOWN Forecast3.9
3rd DOWN Forecast3.86
4th DOWN Forecast3.81
 
ALNOX Weekly Forecast
4th UP Forecast4.08
3rd UP Forecast4.05
2nd UP Forecast4.03
1st UP Forecast4.01
1st DOWN Forecast3.95
2nd DOWN Forecast3.93
3rd DOWN Forecast3.91
4th DOWN Forecast3.88
 
ALNOX Forecast2025
4th UP Forecast15.43
3rd UP Forecast11.76
2nd UP Forecast9.49
1st UP Forecast7.22
1st DOWN Forecast0.74
2nd DOWN Forecast-1.53
3rd DOWN Forecast-3.8
4th DOWN Forecast-7.47
 
 
ALNOX Other Details
Segment EQ
Market Capital 18733114.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ALNOX Address
ALNOX
 
ALNOX Latest News
 
Your Comments and Response on NOXXON Pharma N.V
 
ALNOX Business Profile
NOXXON Pharma N.V., a clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany. Its Spiegelmer platform has a proprietary pipeline of clinical-stage product candidates, including its lead cancer drug candidate, NOX-A12, which is under development as a combination therapy for various cancer indications, such as metastatic pancreatic and colorectal cancer, glioblastoma, myeloma, and chronic lymphocytic leukemia. It is also developing NOX-E36, which has completed Phase IIa clinical trial for the treatment of diabetic nephropathy. The company has a collaboration agreement with Merck & Co. Inc. to study NOX-A12 combined with Keytruda/pembrolizumab inhibitor antibody in patients with metastatic solid tumors. NOXXON Pharma N.V. was founded in 1997 and is based in Berlin, Germany. Address: Max-Dohrn-Strasse 8-10, Berlin, Germany, 10589
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service